- Home
- / Elanix Biotechnologies
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Elanix Biotechnologies financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€0.1
2023-08-04
Market Capitalization
€6 M
2023-08-02
Revenue
€62 K
FY, 2018
CreditSafe Score
?
Score changed on Jul 24, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 |
|---|---|
| Revenue | 62.0K |
| Cost of goods sold | 281.0K |
| Gross profit | (213.0K) |
| Operating expense total | 3.3M |
| Depreciation and amortization | 146.0K |
| EBITDA | (3.5M) |
| EBIT | (3.7M) |
| Interest expense | 10.0K |
| Pre tax profit | (3.5M) |
| Income tax expense | 273.0K |
| Net Income | (3.7M) |